Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOZINAMERAN for Immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 207 adverse event reports in the FDA FAERS database where TOZINAMERAN was used for Immunisation.

Most Reported Side Effects for TOZINAMERAN

Side Effect Reports % Deaths Hosp.
Fatigue 1,197 17.5% 20 333
Headache 904 13.2% 16 231
Covid-19 896 13.1% 22 307
Pain in extremity 675 9.9% 10 189
Pyrexia 665 9.7% 31 176
Pain 633 9.3% 7 161
Drug ineffective 547 8.0% 21 138
Nausea 473 6.9% 18 166
Arthralgia 464 6.8% 1 124
Off label use 446 6.5% 17 142
Dyspnoea 443 6.5% 26 212
Asthenia 389 5.7% 22 174
Dizziness 377 5.5% 6 146
Malaise 367 5.4% 24 125
Rash 335 4.9% 3 81

Other Indications for TOZINAMERAN

Covid-19 immunisation (4,585) Product used for unknown indication (1,072) Covid-19 prophylaxis (377) Covid-19 (131) Prophylaxis (100) Adverse drug reaction (9) Covid-19 treatment (6)

Other Drugs Used for Immunisation

INFLUENZA VIRUS VACCINE (560) PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281) COVID-19 VACCINE NOS (269) MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148) PNEUMOCOCCAL VACCINE POLYVALENT (140) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123) AD26.COV2.S (113) STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111) MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN (110)

Related Pages

TOZINAMERAN Full Profile All Immunisation Drugs TOZINAMERAN Demographics TOZINAMERAN Timeline